178 related articles for article (PubMed ID: 33719495)
1. Long-Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy.
Kubuš P; Rubáčková Popelová J; Kovanda J; Sedláček K; Janoušek J
J Am Heart Assoc; 2021 Mar; 10(6):e018302. PubMed ID: 33719495
[TBL] [Abstract][Full Text] [Related]
2. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease.
Yin Y; Dimopoulos K; Shimada E; Lascelles K; Griffiths S; Wong T; Gatzoulis MA; Babu-Narayan SV; Li W
J Am Heart Assoc; 2019 Nov; 8(21):e012744. PubMed ID: 31657270
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
[TBL] [Abstract][Full Text] [Related]
5. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
[TBL] [Abstract][Full Text] [Related]
7. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy.
Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR
JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cardiac Resynchronization Therapy on Heart Transplant-Free Survival in Pediatric and Congenital Heart Disease Patients.
Chubb H; Rosenthal DN; Almond CS; Ceresnak SR; Motonaga KS; Arunamata AA; Long J; Trela AV; Hanisch D; McElhinney DB; Dubin AM
Circ Arrhythm Electrophysiol; 2020 Apr; 13(4):e007925. PubMed ID: 32202126
[TBL] [Abstract][Full Text] [Related]
9. Predictors of long-term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block.
Biton Y; Costa J; Zareba W; Baman JR; Goldenberg I; McNitt S; Solomon SD; Polonsky B; Kutyifa V
Clin Cardiol; 2018 Oct; 41(10):1358-1366. PubMed ID: 30141210
[TBL] [Abstract][Full Text] [Related]
10. 16 Years of Cardiac Resynchronization Pacing Among Congenital Heart Disease Patients: Direct Contractility (dP/dt-max) Screening When the Guidelines Do Not Apply.
Karpawich PP; Bansal N; Samuel S; Sanil Y; Zelin K
JACC Clin Electrophysiol; 2017 Aug; 3(8):830-841. PubMed ID: 29759779
[TBL] [Abstract][Full Text] [Related]
11. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
[TBL] [Abstract][Full Text] [Related]
12. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in adults with congenital heart disease.
Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L
Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy for various systemic ventricular morphologies in patients with congenital heart disease.
Sakaguchi H; Miyazaki A; Yamada O; Kagisaki K; Hoashi T; Ichikawa H; Ohuchi H
Circ J; 2015; 79(3):649-55. PubMed ID: 25746550
[TBL] [Abstract][Full Text] [Related]
15. Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle.
Jacquemart E; Combes N; Duthoit G; Bessière F; Ladouceur M; Iserin L; Laredo M; Bredy C; Maltret A; Di Filippo S; Hascoët S; Pasquié JL; Marijon E; Waldmann V
Heart Rhythm; 2022 Apr; 19(4):658-666. PubMed ID: 34863963
[TBL] [Abstract][Full Text] [Related]
16. Remarkable response to cardiac resynchronization therapy via left bundle branch pacing in patients with true left bundle branch block.
Guo J; Li L; Xiao G; Ye T; Huang X; Meng F; Li Q; Chen S; Cai B
Clin Cardiol; 2020 Dec; 43(12):1460-1468. PubMed ID: 32960993
[TBL] [Abstract][Full Text] [Related]
17. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
Dreger H; Borges AC; Baumann G; Melzer C
Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960
[TBL] [Abstract][Full Text] [Related]
18. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.
Rickard J; Johnston DR; Price J; Tedford R; Baranowski B; Bassiouny M; Cantillon D; Grimm RA; Tang WHW; Varma N; Wilkoff BL
Heart Rhythm; 2015 Mar; 12(3):517-523. PubMed ID: 25460866
[TBL] [Abstract][Full Text] [Related]
19. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
[TBL] [Abstract][Full Text] [Related]
20. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
